Results 111 to 120 of about 13,185 (241)
Background: Patients with a mechanical prosthetic heart valve implantation need to be treated with a vitamin K antagonist (VKA) due to a substantially high risk of thromboembolism. In this study we report data on patients with mechanical heart valves (MV)
Carioli E +69 more
core +1 more source
Results of heart valve replacement with the SORIN prosthesis.
From March 1977 to December 1981, 872 patients at our institution underwent valve replacement with a pyrolytic carbon tilting disc prosthesis manufactured in Italy by SORIN-Biomedica. To verify the performance characteristics of this prosthesis, we analyzed the intermediate-term results obtained over a cumulative total of 3,041 patient-years (pt-yr) of
T. Colombo +4 more
openaire +2 more sources
A and B: Right atrial voltage mapping identified a limited region of viable myocardium within an extensive atrial scar. C: Intracardiac echocardiography guided safe deployment of an atrial leadless pacemaker. D and E: Fluoroscopy confirmed stable device positioning in the right atrial appendage of the patient.
Kridhitach Ngarmukos +2 more
wiley +1 more source
Pericardial bioprosthetic heart valves were introduced into clinical practice more than 30 years ago. Unfortunately, the long-term results were initially disappointing, particularly with regard to the limited durability of the prosthesis.
Alamanni F. +6 more
core
Bioprosthesis versus Mechanical Valve Heart Prosthesis: Assessment of Quality of Life
Background: The aim of this study was to evaluate the QoL of patients undergoing heart valve replacement using the SF-36 questionnaire, compare it between patients with mechanical prosthesis and patients with bioprosthesis, and correlate the results with
Joice Anaize Tonon do Amaral (7574402) +4 more
core +1 more source
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen +15 more
wiley +1 more source
Anticoagulation in pregnancy with mechanical heart valves: 10-year experience
Anticoagulation in pregnancy was evaluated in 33 women with a mechanical heart valve prosthesis who had 53 pregnancies between 1994 and 2006. Their mean age at valve operation was 24.4 ± 5.4 years, and 22 (67%) had isolated mitral valve disease. Of these
Khan, Jawad S +4 more
core +1 more source
Abstract Background Atrial fibrillation (AF) poses significant challenges for coronary CT angiography (CCTA) due to R‐R interval variability, often necessitating high radiation dose protocols. Absolute phase gating, which uses fixed millisecond delays rather than percentage‐based cardiac cycle timing, may optimize image quality while reducing radiation
Yuyang Li
wiley +1 more source
ABSTRACT Transvalvular device leads are undesirable following tricuspid valve replacement. Simultaneous lead extraction and intra‐operative EV‐ICD implantation can provide ongoing defibrillator therapy without crossing the prosthetic valve and may avoid the need for additional pacing hardware when atrioventricular conduction is preserved.
Joseph Canavan +3 more
wiley +1 more source
Background Patients with mechanical heart valves require lifelong oral anticoagulation with vitamin K antagonists such as warfarin to prevent valve-associated thromboembolism.
Melanie Poloczek, Barbara Kipp
doaj +1 more source

